![]() |
|
遺伝子、ベクター、構造体、クローンの開発 下流での成功につながる上流での判断1月9日〜10日 生物学的療法に利用可能な高品質のタンパク質に対する需要がかつてない規模に拡大しています。機能性タンパク質の生産をこれまでよりも高い水準に引き上げるという目標を達成するには、工学(科学)と洞察(方法論)が必要になります。生物療法用タンパク質の効果的な発現という課題は、科学と方法論の両方に関わるテーマなのです。この部会は、生物療法用の機能性タンパク質製品へとつながるようなタンパク質発見研究にタンパク質工学の効果的な戦略を応用するという前回までのテーマを踏襲したもので、経験豊富な研究者が披露する現場での経験や応用技術、研究成果などから多くのことを学び取ることができます。 遺伝子の標的化 Efficient Optimization of Protein Expression Using High-Throughput Gene Synthesis and Screens Jingdong Tian, Ph.D., Assistant Professor, Biomedical Engineering, Duke University Semi-Automatic Cloning and Expression of Immunoglobulin Genes from Single-Plasma Cells for High-Throughput Generation of Monoclonal Antibodies Masaharu Isobe, Ph.D., Professor, Molecular and Cellular Biology, Life Sciences and Bioengineering, University of Toyama
ベクターの構成 The Use of a Combinatorial Recombinational Cloning Platform to Simplify Construction of Expression Vectors for Wide-Ranging Areas of Proteomic and Genetic Research Dominic Esposito, Ph.D., Interim Director, Protein Expression Laboratory; Group Leader, Clone Optimization Group, Advanced Technology Program, SAIC-Frederick, Inc. Parallel Construct Expression Evaluation Using a High-Throughput Process for Baculovirus-Infected Insect Cells W. Clay Brown, Ph.D., High-Throughput Protein Lab, Center for Structural Biology, Life Sciences Institute, University Re-Engineering Multicloning Sites for Function and Convenience Hal Alper, Ph.D., Assistant Professor, Chemical Engineering, University of Texas at Austin So Many Options, So Little Money: How to Choose the Right Vector and Screen for Functional Proteins Bill Gillette, Ph.D., Senior Scientist, Group Leader, Protein Expression Laboratory, Advanced Technology Program, SAIC-Frederick, Inc.
発現系の開発 Maximizing Recombinant Protein Expression Through Systematic Gene Design Mark Welch, Director, Gene Design, DNA2.0 Engineering and Evaluation of Mammalian Secreted Protein Expression Library for High-Throughput Target Discovery Tadas Panavas, Ph.D., Senior Scientist, Molecular and Protein Biosciences, Centocor R&D, Inc. Development of Expression-Ready Constructs for Generation of Proteomic Libraries Susan Celniker, Ph.D., Co-Director, Life Sciences, Lawrence Berkeley National Laboratory Driving a Variant of the Methanol-Inducible AOX1 Promoter from Pichia pastoris with Glycerol for High-Level Expression of (Therapeutic) Proteins Roland Weis, Ph.D., Head, Operations, VTU Technology GmbH, Austria Influence of Histidine Affinity Tags on Protein Structural Order Evelina Angov, M.S., Ph.D., Microbiologist, Malaria Vaccine Development, Walter Reed Army Institute of Research |